ClinicalTrials.gg
Drug

Linaclotide clinical trials

Also written Linzess, ASP0456 and MD-1100 Acetate.

studies test it
44
open now
3
in phase 3
14
first study started
2006

How each study uses linaclotide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the linaclotide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Aug 2012 · LINZESS · NDA 202811 (FDA, Drugs@FDA)
European Union
26 Nov 2012 · Constella · EMEA/H/C/002490 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Linaclotide
28
Linaclotide 290 micrograms
7
linaclotide acetate
3
[9-L-tyrosine]heat-stable enterotoxin (Escherichia coli)-(6-19)-peptide
2

Brand

Linzess
16

Development codes

ASP0456
6
MD-1100 Acetate
5
MM-416775
1

Studies by the year they started

44 studies that test it; most in 2014 (7)

Studies that test linaclotide, by start year
YearStudies
20063
20071
20084
20091
20101
20111
20122
20132
20147
20156
20162
20181
20193
20213
20222
20232
20241
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
13
Phase 3
14
Phase 4
6
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 31 · Other 13

Ironwood Pharmaceuticals, Inc. (10) · Forest Laboratories (9) · Astellas Pharma Inc (6) · AbbVie (3) · University of Nottingham (2) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of Wisconsin, Madison (1) · Universitaire Ziekenhuizen KU Leuven (1)

Often tested with

Tested in the same studies.

Plecanatide (1) · Lactulose (1) · Polyethylene Glycols (1) · Senna Extract (1) · Sennosides (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test linaclotide.

Studies

Open first, then newest update. How each study uses linaclotide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 44

See all 44 studies that test linaclotide →

Codes

What other systems call linaclotide · ClinicalTrials.gg INT005166

  • MeSH (NLM) C523483linaclotideConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) N0TXR0XR5XLINACLOTIDEConfirmed FDA, NLM
  • RxNorm 1307404One source FDA
  • NCI Thesaurus C81001LinaclotideOne source FDA

Also registered as linaclotide acetate (UNII NSF067KU1M).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.